BioVie Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioVie Inc. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $0.00.
- BioVie Inc. stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $39.20K, a 20.00% decline year-over-year.
- BioVie Inc. stock issued during period, value, issued for services for the quarter ending 2019-06-30 was $0.00.
- BioVie Inc. stock issued during period, value, issued for services for the quarter ending 2019-03-31 was $49.00K, a 79.79% decline year-over-year.
- BioVie Inc. stock issued during period, value, issued for services for fiscal 2020 was $39.20K, a 20.00% decline from fiscal 2019.
- BioVie Inc. stock issued during period, value, issued for services for fiscal 2019 was $49.00K, a 92.52% decline from fiscal 2018.
- BioVie Inc. stock issued during period, value, issued for services for fiscal 2018 was $655.32K.
- BioVie Inc. stock issued during period, value, issued for services for fiscal 2013 was $15.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-30 | $39.20K 10-K · filed 2021-08-30 |
| 2020-03-31 | $39.20K 10-Q · filed 2021-05-10 | |
| 2019-06-30 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-08-07 | $49.00K 10-K/A · filed 2020-08-07 |
| 2019-03-31 | $49.00K 10-Q · filed 2020-05-13 | |
| 2018-06-30 | $655.32K 10-K · filed 2019-09-27 | |
| 2018-03-31 | $242.40K 10-Q · filed 2019-05-10 | $676.90K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $34.50K 10-Q · filed 2019-05-10 | $744.50K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-09-30 | $330.00K 10-Q · filed 2019-05-10 | $805.00K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-06-30 | $70.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2017-11-08 | $480.00K 10-Q · filed 2017-11-08 |
| 2017-03-31 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-09 | |
| 2016-12-31 | $95.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2017-02-07 | |
| 2016-09-30 | $5.00K 10-Q/A · filed 2017-01-19 | |
| 2014-06-30 | -$12.41K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-05-23 | $2.59K 10-Q · filed 2016-05-23 |
| 2014-03-31 | $15.00K 10-Q · filed 2014-05-09 | |
| 2013-09-30 | $15.00K 10-Q · filed 2014-11-13 | |
| 2013-06-30 | $15.00K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |